The use of tranexamic acid in reducing bleeding complications

1. Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) 1980;14:41-7.10.1136/jcp.33.Suppl_14.41Search in Google Scholar

2. Wikipedia. Tranexamic acid. Available from: https://en.wikipedia.org/wiki/Tranexamic_acid (accessed 18 March 2016).Search in Google Scholar

3. Grassin-Delyle S, Tremey B, Abe E, et al. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2013;111:916-24.10.1093/bja/aet25523880099Search in Google Scholar

4. Pfizer Ltd. Cyclokapron injection. 5.1 Pharmacodynamic properties. March 2016. Available from: www.medicines.org.uk/emc/medicine/1489#PHARMACODYNAMIC_PROPS (accessed 18 March 2016).Search in Google Scholar

5. Wesley MC, Pereira LM, Scharp LA, et al. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2015;122:746-58.10.1097/ALN.000000000000057025585004Search in Google Scholar

6. Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia 2015;70 Suppl 1:50-3, e18.10.1111/anae.1291025440395Search in Google Scholar

7. Ng W, Jerath A, Wąsowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther 2015;47:339-50.10.5603/AIT.a2015.001125797505Search in Google Scholar

8. Sperzel M, Huetter J. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost 2007;5:2113-8.10.1111/j.1538-7836.2007.02717.x17666018Search in Google Scholar

9. Rea CJ, Foley JH, Bevan DH, et al. An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A. Ann Hematol 2014;93:683-92.10.1007/s00277-013-1921-z24193375Open DOISearch in Google Scholar

10. Tran HT, Sorensen B, Rea CJ, et al. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors. Haemophilia 2014;20:369-75.10.1111/hae.1231824251535Search in Google Scholar

11. PharmLine Uganda. Tranexamic acid. Available from: http://www.pharmlineug.com/search.php?drug=Tranexamic%20Acid (accessed 22 March 2016).Search in Google Scholar

12. MedIndia. Drug “tranexamic acid” price list. Available from: http://www.medindia.net/drug-price/tranexamic-acid.htm (accessed 22 March 2016).Search in Google Scholar

13. Pfizer Ltd. Cyclokapron injection. 6. Pharmaceutical particulars. March 2016. Available from: www.medicines.org.uk/emc/medicine/1489#PHARMACEUTICAL_PARTS (accessed 22 March 2016).Search in Google Scholar

14. Pfizer, Pharmacia & Upjohn. Cyclokapron label. December 2014. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2014/019281s033lbl.pdf (accessed 22 March 2016).Search in Google Scholar

15. de Guzman R, Polykratis IA, Sondeen JL, et al. Stability of tranexamic acid after 12-week storage at temperatures from -20°c to 50°c. Prehosp Emerg Care 2013;17:394-400.10.3109/10903127.2013.79289123734991Open DOISearch in Google Scholar

16. Ferring Pharmaceuticals. Lysteda prescribing information. October 2013. Available from: www.lysteda.com/assets/pi_ferring2013-1f2d77bcb42b5738c55afab5280d7e9c.pdf (accessed 22 March 2016).Search in Google Scholar

17. Pfizer Ltd. Cyclokapron tablets. February 2014. Available from: www. medicines.org.uk/emc/medicine/16512 (accessed 22 March 2016).Search in Google Scholar

18. MedIndia. Tranexamic acid - drug information. Available from: www.medindia.net/doctors/drug_information/tranexamic_acid.htm (accessed 22 March 2016).Search in Google Scholar

19. Thall Bastow BD. Teratology and drug use during pregnancy. Medscape. 2016. Available from: http://emedicine.medscape.com/article/260725- overview#a5 (accessed 21 April 2016).Search in Google Scholar

20. Gilad O, Merlob P, Stahl B, et al. Outcome following tranexamic acid exposure during breastfeeding. Breastfeed Med 2014;9:407-10.10.1089/bfm.2014.002725025926Search in Google Scholar

21. World Federation of Hemophilia. Guidelines for the management of hemophilia. 2nd ed. 2012. Available from: www1.wfh.org/publications/files/pdf-1472.pdf (accessed 23 March 2016).Search in Google Scholar

22. van Galen KPM, Engelen ET, Mauser-Bunschoten EP, et al. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. Cochrane Database of Systematic Reviews 2015, issue 12, art. no.: CD011385. doi: 10.1002/14651858.CD011385.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011385.pub2/full (accessed 21 April 2016).Search in Google Scholar

23. Forbes CD, Barr RD, Reid G, et al. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J 1972;2:311-3.10.1136/bmj.2.5809.31117881884553818Search in Google Scholar

24. Lee AP, Boyle CA, Savidge GF, et al. Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash. Br Dent J 2005;198:33-8.10.1038/sj.bdj.481195515716891Search in Google Scholar

25. Nuvvula S, Gaddam KR, Kamatham R. Efficacy of tranexamic acid mouthwash as an alternative for factor replacement in gingival bleeding during dental scaling in cases of hemophilia: a randomized clinical trial. Contemp Clin Dent 2014;5:49-53.10.4103/0976-237X.128663401211724808695Search in Google Scholar

26. Federici AB, Sacco R, Stabile F, et al. Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases. Haemophilia 2000;6:71-7.10.1046/j.1365-2516.2000.00370.x10781191Open DOISearch in Google Scholar

27. Franchini M, Rossetti G, Tagliaferri A, et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years’ experience in three Italian hemophilia centers. Haemophilia 2005;11:504-9.10.1111/j.1365-2516.2005.01132.x16128895Search in Google Scholar

28. Frachon X, Pommereuil M, Berthier AM, et al. Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:270-5.10.1016/j.tripleo.2004.06.07115716831Search in Google Scholar

29. Givol N, Hirschhorn A, Lubetsky A, et al. Oral surgery-associated postoperative bleeding in haemophilia patients - a tertiary centre’s two decade experience. Haemophilia 2015;21:234-40.10.1111/hae.1257325470999Search in Google Scholar

30. Zanon E, Martinelli F, Bacci C, et al. Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia 2000;6:533-6.10.1046/j.1365-2516.2000.00423.x11012698Open DOISearch in Google Scholar

31. Nickles K, Wohlfeil M, Alesci S, et al. Comprehensive treatment of periodontitis in patients with von Willebrand disease. J Periodontol 2010;81:1432-40.10.1902/jop.2010.10007620594049Search in Google Scholar

32. Hewson I, Makhmalbaf P, Street A, et al. Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital. Haemophilia 2011;17:e185-8.10.1111/j.1365-2516.2010.02346.x20557354Search in Google Scholar

33. Coppola A, Windyga J, Tufano A, et al. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database of Systematic Reviews 2015, issue 2, art. no.: CD009961. doi: 10.1002/14651858.CD009961.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009961.pub2/abstract (accessed 21 April 2016).Search in Google Scholar

34. Valentino LA, Holme PA. Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly? Haemophilia 2015;21:709-14.Search in Google Scholar

35. Holmström M, Tran HT, Holme PA. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia 2012;18:544-9.10.1111/j.1365-2516.2012.02748.x22348384Open DOISearch in Google Scholar

36. Takedani H, Shima M, Horikoshi Y, et al. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan. Haemophilia 2015;21:374-9.10.1111/hae.1261125521821Search in Google Scholar

37. Rossi M, Jayaram R, Sayeed R. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes? Interact Cardiovasc Thorac Surg 2011;13:320-31.Search in Google Scholar

38. Siboni SM, Biguzzi E, Pasta G, et al. Management of orthopaedic surgery in rare bleeding disorders. Haemophilia 2014;20:693-701.10.1111/hae.1238724612427Open DOISearch in Google Scholar

39. Siboni SM, Biguzzi E, Solimeno LP, et al. Orthopaedic surgery in patients with von Willebrand disease. Haemophilia 2014;20:133-40.10.1111/hae.1225823992395Open DOISearch in Google Scholar

40. Livnat T, Tamarin I, Mor Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost 2009;102:487-92.10.1160/TH09-03-017219718468Search in Google Scholar

41. Sarris I, Arafa A, Konaris L, et al. Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases. Haemophilia 2007;13:115-6.10.1111/j.1365-2516.2006.01386.x17212738Open DOISearch in Google Scholar

42. Yilmaz D, Akin M, Ay Y, et al. A single centre experience in circumcision of haemophilia patients: Izmir protocol. Haemophilia 2010;16:888-91.10.1111/j.1365-2516.2010.02324.x20491959Open DOISearch in Google Scholar

43. Davis A, Walsh M, McCarthy P, et al. Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study. Haemophilia 2013;19:583-9.10.1111/hae.1214623560720Open DOISearch in Google Scholar

44. Ragni MV, Machin N, Malec LM, et al. Von Willebrand factor for menorrhagia: a survey and literature review. Haemophilia 2016 Feb 4. doi: 10.1111/hae.12898 [Epub ahead of print].Search in Google Scholar

45. Chi C, Pollard D, Tuddenham EG, Kadir RA. Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol 2010;23:215-22.10.1016/j.jpag.2009.11.00820471874Open DOISearch in Google Scholar

46. Rodeghiero F. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin. Haemophilia 2008;14 Suppl 1:21-30.10.1111/j.1365-2516.2007.01611.x18173691Search in Google Scholar

47. Kouides PA, Byams VR, Philipp CS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009;145:212-20.10.1111/j.1365-2141.2009.07610.x19236375Search in Google Scholar

48. European Medicines Agency. Assessment report. Antifibrinolytics containing aprotinin, aminocaproic acid and tranexamic acid. Tranexamic acid. EMA/680967/2012. October 2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Antifibrinolytic_medicines/WC500153603.pdf (accessed 21 April 2016).Search in Google Scholar

49. Lecker I, Wang DS, Whissell PD, et al. Tranexamic acid-associated seizures: causes and treatment. Ann Neurol 2016;79:18-26.10.1002/ana.24558473844226580862Search in Google Scholar

50. Okamoto S, Okamoto U. Amino-methyl-cyclohexane carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis. Keio J Med 1962;11:105-15. Available from: https://www.jstage.jst.go.jp/article/kjm1952/11/3/11_3_105/_pdf (accessed 21 April 2016).10.2302/kjm.11.105Search in Google Scholar